Quality by design-based method development for the determination of related substances of ezetimibe by high performance liquid chromatography

1 Molnár I. - Searching for robust HPLC methods - Csaba Horváth and the Solvophobic Theory, Chromatographia, 2005,62:s7-17. Search in Google Scholar

2 Olsen BA, Castle BC, Myers DP. - Advances in HPLC technology for the determination of drug impurities, TrAC Trends Anal Chem, 2006,25:796-805. Search in Google Scholar

3 Görög S. - Critical review of reports on impurity and degradation product profiling in the last decade, TrAC Trends Anal Chem, 2018,101:2-16. Search in Google Scholar

4 Ferencz E, Kelemen ÉK, Obreja M, Sipos E, Vida S, Urkon M, et al. - Computer-assisted UHPLC method development and optimization for the determination of albendazole and its related substances, J Pharm Biomed Anal, 2021,203:114203. Search in Google Scholar

5 Kormány R, Molnár I, Fekete J. - Renewal of an old European Pharmacopoeia method for Terazosin using modeling with mass spectrometric peak tracking, J Pharm Biomed Anal, 2017,135:8-15. Search in Google Scholar

6 Enesei D, Kapui I, Fekete S, Kormány R. - Updating the European Pharmacopoeia impurity profiling method for terazosin and suggesting alternative columns, J Pharm Biomed Anal, 2020,187:113371. Search in Google Scholar

7 Horvath C, Melander W, Molnar I. - Solvophobic interactions in liquid chromatography with nonpolar stationary phases, J Chromatogr, 1976,125:129-56. Search in Google Scholar

8 Horváth C, Melander W, Molnár I. - Liquid Chromatography of Ionogenic Substances with Nonpolar Stationary Phases, Anal Chem, 1977,49:142-54. Search in Google Scholar

9 Horvath C, Melander W, Molnar I, Molnar P. - Enhancement of Retention by Ion-Pair Formation in Liquid Chromatography with Nonpolar Stationary Phases, Anal Chem, 1977,49:2295-305. Search in Google Scholar

10 International Council for Harmonisation. ICH Q8 (R2) -Pharmaceutical Development. 2009,. Search in Google Scholar

11 Grangeia HB, Silva C, Simőes SP, Reis MS. - Quality by design in pharmaceutical manufacturing: a systematic review of current status, challenges and future perspectives, Eur J Pharm Biopharm, 2020,147:19-37. Search in Google Scholar

12 Tome T, Žigart N, Časar Z, Obreza A. - Development and Optimization of Liquid Chromatography Analytical Methods by Using AQbD Principles: Overview and Recent Advances, Org Process Res Dev, 2019,23:1784-802. Search in Google Scholar

13 Peraman R, Bhadraya K, Padmanabha Reddy Y. - Analytical quality by design: a tool for regulatory flexibility and robust analytics, Int J Anal Chem, 2015,2015:868727. Search in Google Scholar

14 Parr MK, Schmidt AH. - Life cycle management of analytical methods, J Pharm Biomed Anal, 2018,147:506-17. Search in Google Scholar

15 Reid G, Margado J, Barnett K, Harrington B, Wang J, Harwood J, et al. - Analytical Quality by Design (AQbD) in Pharmaceutical Development | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology, Am Pharm Rev, 2013,. https://www.americanpharmaceuticalre-view.com/Featured-Articles/144191-Analytical-Quality-by-Design-AQbD-in-Pharmaceutical-Development/ (accessed July 26, 2022). Search in Google Scholar

16 Kochling J, Wu W, Hua Y, Guan Q, Castaneda-Merced J. - A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC-MS methods development for protein analysis, J Pharm Biomed Anal, 2016,125:130-9. Search in Google Scholar

17 Wechsler J. - Quality by Design for Analytical Methods: Implications for Method Validation and Transfer, Pharm Tehnol, 2012,. https://www.pharmtech.com/view/quality-design-analytical-methods-implications-method-validation-and-transfer (accessed July 27, 2022). Search in Google Scholar

18 Tome T, Casar Z, Obreza A. - Development of a Unified Reversed-Phase HPLC Method for Efficient Determination of EP and USP Process-Related Impurities in Celecoxib Using Analytical Quality by Design Principles, Molecules, 2020,25:809. Search in Google Scholar

19 Internationa Council for Harmonisation. ICH Q14 - Analytical Procedure Development - draft. 2022,. Search in Google Scholar

20 DryLab, n.d. https://molnar-institute.com/drylab/ (accessed September 16, 2020). Search in Google Scholar

21 Lewis JA, Lommen DC, Raddatz WD, Dolan JW, Snyder LR, Molnar I. - Computer simulation for the prediction of separation as a function of pH for reversed-phase high-performance liquid chromatography: I. Accuracy of a theory-based model, J Chromatogr A, 1992,592:183-95. Search in Google Scholar

22 Molnar I. - Computerized design of separation strategies by reversed-phase liquid chromatography: development of DryLab software, J Chromatogr A, 2002,965:175-94. Search in Google Scholar

23 Molnár I, Monks KE. - From Csaba Horváth to Quality by Design: Visualizing Design Space in Selectivity Exploration of HPLC Separations, Chromatographia, 2011,1:5-14. Search in Google Scholar

24 Kormány R, Rácz N, Fekete S, Horváth K. - Development of a Fast and Robust UHPLC Method for Apixaban In-Process Control Analysis, Molecules, 2021,26:3505. Search in Google Scholar

25 Guichard N, Fekete S, Guillarme D, Bonnabry P, Fleury-Souverain S. - Computer-assisted UHPLC-MS method development and optimization for the determination of 24 antineo-plastic drugs used in hospital pharmacy, J Pharm Biomed Anal, 2019,164:395-401. Search in Google Scholar

26 Rácz N, Molnár I, Zöldhegyi A, Rieger HJ, Kormány R. -Simultaneous optimization of mobile phase composition and pH using retention modeling and experimental design, J Pharm Biomed Anal, 2018,160:336-43. Search in Google Scholar

27 Zöldhegyi A, Rieger HJ, Molnár I, Fekhretdinova L. -Automated UHPLC separation of 10 pharmaceutical compounds using software-modeling, J Pharm Biomed Anal, 2018,156:379-88. Search in Google Scholar

28 Fekete S, Molnár I. Software-Assisted Method Development in High Performance Liquid Chromatography. World Scientific (Europe); 2018,. Search in Google Scholar

29 Jayaraman K, Rajendran AK, Kumar GS, Bhutani H. - A methodology employing retention modeling for achieving control space in liquid chromatography method development using quality by design approach, J Chromatogr A, 2021,1635:461658. Search in Google Scholar

30 Ferencz E, Zöldhegyi A, Kelemen ÉK, Obreja M, Urkon M, Sipos E, et al. - Analytical quality by design-compliant retention modeling for exploring column interchangeabilities in separating ezetimibe and its related substances, J Chromatogr A, 2022,1682:463494. Search in Google Scholar

31 Bays H. - Ezetimibe, Expert Opin Investig Drugs, 2005,11:1587-604. Search in Google Scholar

32 Kang MK. - Ezetimibe, Stroke Revisit Dyslipidemia Stroke, 2021,8:91-101. Search in Google Scholar

33 Shaya FT, Sing K, Milam R, Husain F, del Aguila MA, Patel MY. - Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses, Am J Cardiovasc Drugs, 2020,20:239-48. Search in Google Scholar

34 Sasikala CHVA, Padi PR, Sunkara V, Ramayya P, Dubey PK, Uppala VBR, et al. - An Improved and Scalable Process for the Synthesis of Ezetimibe: An Antihypercholesterolemia Drug†, Org Process Res Dev, 2009,13:907-10. Search in Google Scholar

35 Śnieżek M, Stecko S, Panfil I, Furman B, Chmielewski M. -Total Synthesis of Ezetimibe, a Cholesterol Absorption Inhibitor, J Org Chem, 2013,78:7048-57. Search in Google Scholar

36 International Council for Harmonisation.ICH Q3A -Impurities in new drug substances. 2006,. Search in Google Scholar

37 International Council for Harmonisation - ICH Q3B -Impurities in new drug products. 2006,. Search in Google Scholar

38 Ezetimibe Tablets monograph. United States Pharmacop. -Natl. Formul., vol. Issue 1, 2022,. Search in Google Scholar

39 Desai PR, Mehta PJ, Ojha SK, Chokshi AB. - Simultaneous quantification of related substances of ezetimibe and simvastatin in combined dosage form using a novel stability-indicating liquid chromatographic method, Acta Chromatogr, 2018,30:85-94. Search in Google Scholar

40 Rocha LP, Cabral LM, Pinto EC, de Sousa VP. - Ezetimibe: A Review of Analytical Methods for the Drug Substance, Pharmaceutical Formulations and Biological Matrices, Crit Rev Anal Chem, 2020,:1-16. Search in Google Scholar

41 Ezetimibe monograph. United States Pharmacop. - Natl. Formul., vol. Issue 1, 2022,. Search in Google Scholar

42 International Council for Harmonisation.ICH Q2 (R1) -Validation of analytical procedures.1995,. Search in Google Scholar

43 Marvin | ChemAxon, n.d. https://chemaxon.com/products/marvin (accessed September 17, 2020). Search in Google Scholar